Record Index Results
Search
Contents
Download
Documentation
About MassBank
News Archive
Index Type :
Instrument Type:
LC-ESI-QFT
Back to Record Index
Results :
15,040 Hit.
( 4,778 - 4,942 Displayed )
First
Prev
27
28
29
30
31
32
33
34
35
36
Next
Last
( Total
88
Page )
▼
Results End
Name
Formula / Structure
ExactMass
ID
Cyclizine
24 spectra
C18H22N2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
266.17831
LC-ESI-QFT; MS2; CE: 10%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002036
LC-ESI-QFT; MS2; CE: 10%; R=30000; [M+H]+
MSBNK-HBM4EU-HB001965
LC-ESI-QFT; MS2; CE: 15%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002037
LC-ESI-QFT; MS2; CE: 20%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002038
LC-ESI-QFT; MS2; CE: 20%; R=30000; [M+H]+
MSBNK-HBM4EU-HB001966
LC-ESI-QFT; MS2; CE: 25%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002039
LC-ESI-QFT; MS2; CE: 30%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002040
LC-ESI-QFT; MS2; CE: 35%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002041
LC-ESI-QFT; MS2; CE: 40%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002042
LC-ESI-QFT; MS2; CE: 40%; R=30000; [M+H]+
MSBNK-HBM4EU-HB001967
LC-ESI-QFT; MS2; CE: 45%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002043
LC-ESI-QFT; MS2; CE: 50%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002044
LC-ESI-QFT; MS2; CE: 55%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002045
LC-ESI-QFT; MS2; CE: 60%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002046
LC-ESI-QFT; MS2; CE: 65%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002047
LC-ESI-QFT; MS2; CE: 70%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002048
LC-ESI-QFT; MS2; CE: 75%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002049
LC-ESI-QFT; MS2; CE: 80%; R=17500; [M+H]+
MSBNK-HBM4EU-HB002050
LC-ESI-QFT; MS2; CE: 80%; R=30000; [M+H]+
MSBNK-HBM4EU-HB001968
LC-ESI-QFT; MS2; CE: CE30; R=17500; [M+H]+
MSBNK-HBM4EU-HB002770
LC-ESI-QFT; MS2; CE: CE45; R=17500; [M+H]+
MSBNK-HBM4EU-HB002771
LC-ESI-QFT; MS2; CE: CE60; R=17500; [M+H]+
MSBNK-HBM4EU-HB002772
LC-ESI-QFT; MS2; CE: CE75; R=17500; [M+H]+
MSBNK-HBM4EU-HB002773
LC-ESI-QFT; MS2; CE: CE90; R=17500; [M+H]+
MSBNK-HBM4EU-HB002774
Cyclohexylamine
1 spectrum
C6H13N
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
99.10480
LC-ESI-QFT; MS2; CE: 35 NCE; R=35000; [M+H]+
MSBNK-CASMI_2016-SM826601
Cyclopamine
6 spectra
C27H41NO2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
411.31369
LC-ESI-QFT; MS2; CE: 15; R=17500; [M+H]+
MSBNK-LCSB-LU065401
LC-ESI-QFT; MS2; CE: 30; R=17500; [M+H]+
MSBNK-LCSB-LU065402
LC-ESI-QFT; MS2; CE: 45; R=17500; [M+H]+
MSBNK-LCSB-LU065403
LC-ESI-QFT; MS2; CE: 60; R=17500; [M+H]+
MSBNK-LCSB-LU065404
LC-ESI-QFT; MS2; CE: 75; R=17500; [M+H]+
MSBNK-LCSB-LU065405
LC-ESI-QFT; MS2; CE: 90; R=17500; [M+H]+
MSBNK-LCSB-LU065406
Cycloxaprid
9 spectra
C14H15ClN4O3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
322.08331
LC-ESI-QFT; MS2; CE: 120%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122007
LC-ESI-QFT; MS2; CE: 15%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122001
LC-ESI-QFT; MS2; CE: 150%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122008
LC-ESI-QFT; MS2; CE: 180%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122009
LC-ESI-QFT; MS2; CE: 30%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122002
LC-ESI-QFT; MS2; CE: 45%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122003
LC-ESI-QFT; MS2; CE: 60%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122004
LC-ESI-QFT; MS2; CE: 75%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122005
LC-ESI-QFT; MS2; CE: 90%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122006
Cycloxydim
12 spectra
C17H27NO3S
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
325.17117
LC-ESI-QFT; MS2; CE: 15; R=35000; [M+H]+
MSBNK-Eawag-EQ304501
LC-ESI-QFT; MS2; CE: 15; R=35000; [M-H]-
MSBNK-Eawag-EQ304551
LC-ESI-QFT; MS2; CE: 30; R=35000; [M+H]+
MSBNK-Eawag-EQ304502
LC-ESI-QFT; MS2; CE: 30; R=35000; [M-H]-
MSBNK-Eawag-EQ304552
LC-ESI-QFT; MS2; CE: 45; R=35000; [M+H]+
MSBNK-Eawag-EQ304503
LC-ESI-QFT; MS2; CE: 45; R=35000; [M-H]-
MSBNK-Eawag-EQ304553
LC-ESI-QFT; MS2; CE: 60; R=35000; [M+H]+
MSBNK-Eawag-EQ304504
LC-ESI-QFT; MS2; CE: 60; R=35000; [M-H]-
MSBNK-Eawag-EQ304554
LC-ESI-QFT; MS2; CE: 75; R=35000; [M+H]+
MSBNK-Eawag-EQ304505
LC-ESI-QFT; MS2; CE: 75; R=35000; [M-H]-
MSBNK-Eawag-EQ304555
LC-ESI-QFT; MS2; CE: 90; R=35000; [M+H]+
MSBNK-Eawag-EQ304506
LC-ESI-QFT; MS2; CE: 90; R=35000; [M-H]-
MSBNK-Eawag-EQ304556
Cycloxydim-TP BH 517-TSO E/Z-isomer
18 spectra
C17H27NO4S
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
341.16611
LC-ESI-QFT; MS2; CE: 120%; R=17500; [M+H]+
MSBNK-Eawag-EQ418207
LC-ESI-QFT; MS2; CE: 120%; R=17500; [M-H]-
MSBNK-Eawag-EQ418257
LC-ESI-QFT; MS2; CE: 15%; R=17500; [M+H]+
MSBNK-Eawag-EQ418201
LC-ESI-QFT; MS2; CE: 15%; R=17500; [M-H]-
MSBNK-Eawag-EQ418251
LC-ESI-QFT; MS2; CE: 150%; R=17500; [M+H]+
MSBNK-Eawag-EQ418208
LC-ESI-QFT; MS2; CE: 150%; R=17500; [M-H]-
MSBNK-Eawag-EQ418258
LC-ESI-QFT; MS2; CE: 180%; R=17500; [M+H]+
MSBNK-Eawag-EQ418209
LC-ESI-QFT; MS2; CE: 180%; R=17500; [M-H]-
MSBNK-Eawag-EQ418259
LC-ESI-QFT; MS2; CE: 30%; R=17500; [M+H]+
MSBNK-Eawag-EQ418202
LC-ESI-QFT; MS2; CE: 30%; R=17500; [M-H]-
MSBNK-Eawag-EQ418252
LC-ESI-QFT; MS2; CE: 45%; R=17500; [M+H]+
MSBNK-Eawag-EQ418203
LC-ESI-QFT; MS2; CE: 45%; R=17500; [M-H]-
MSBNK-Eawag-EQ418253
LC-ESI-QFT; MS2; CE: 60%; R=17500; [M+H]+
MSBNK-Eawag-EQ418204
LC-ESI-QFT; MS2; CE: 60%; R=17500; [M-H]-
MSBNK-Eawag-EQ418254
LC-ESI-QFT; MS2; CE: 75%; R=17500; [M+H]+
MSBNK-Eawag-EQ418205
LC-ESI-QFT; MS2; CE: 75%; R=17500; [M-H]-
MSBNK-Eawag-EQ418255
LC-ESI-QFT; MS2; CE: 90%; R=17500; [M+H]+
MSBNK-Eawag-EQ418206
LC-ESI-QFT; MS2; CE: 90%; R=17500; [M-H]-
MSBNK-Eawag-EQ418256
Cyenopyrafen
6 spectra
C24H31N3O2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
393.24161
LC-ESI-QFT; MS2; CE: 15%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122101
LC-ESI-QFT; MS2; CE: 30%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122102
LC-ESI-QFT; MS2; CE: 45%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122103
LC-ESI-QFT; MS2; CE: 60%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122104
LC-ESI-QFT; MS2; CE: 75%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122105
LC-ESI-QFT; MS2; CE: 90%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122106
Cyflumetofen
8 spectra
C24H24F3NO4
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
447.16571
LC-ESI-QFT; MS2; CE: 120%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122207
LC-ESI-QFT; MS2; CE: 15%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122201
LC-ESI-QFT; MS2; CE: 150%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122208
LC-ESI-QFT; MS2; CE: 30%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122202
LC-ESI-QFT; MS2; CE: 45%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122203
LC-ESI-QFT; MS2; CE: 60%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122204
LC-ESI-QFT; MS2; CE: 75%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122205
LC-ESI-QFT; MS2; CE: 90%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122206
Cymiazole
9 spectra
C12H14N2S
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
218.08780
LC-ESI-QFT; MS2; CE: 120%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122407
LC-ESI-QFT; MS2; CE: 15%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122401
LC-ESI-QFT; MS2; CE: 150%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122408
LC-ESI-QFT; MS2; CE: 180%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122409
LC-ESI-QFT; MS2; CE: 30%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122402
LC-ESI-QFT; MS2; CE: 45%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122403
LC-ESI-QFT; MS2; CE: 60%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122404
LC-ESI-QFT; MS2; CE: 75%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122405
LC-ESI-QFT; MS2; CE: 90%; R=17500; [M+H]+
MSBNK-Eawag-EQ01122406
Cymoxanil-TP IN-KQ960
4 spectra
C7H12N4O4
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
216.08591
LC-ESI-QFT; MS2; CE: 15%; R=17500; [M-H]-
MSBNK-Eawag-EQ421051
LC-ESI-QFT; MS2; CE: 30%; R=17500; [M-H]-
MSBNK-Eawag-EQ421052
LC-ESI-QFT; MS2; CE: 45%; R=17500; [M-H]-
MSBNK-Eawag-EQ421053
LC-ESI-QFT; MS2; CE: 60%; R=17500; [M-H]-
MSBNK-Eawag-EQ421054
CYP_p_168.0767_12.4
1 spectrum
C7H9N3O2
167.06950
LC-ESI-QFT; MS2; CE: 90%; R=17500; [M+H]+
MSBNK-Eawag_Additional_Specs-ET401601
Cypermethrin
1 spectrum
C22H19Cl2NO3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
415.07419
LC-ESI-QFT; MS2; CE: Ramp 20%-70% (nominal); R=30000; [M+H]+
MSBNK-ACES_SU-AS000170
Cypermethrin-3-phenoxybenzoic-acid (TENTATIVE)
1 spectrum
C8H10Cl2O2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
208.00580
LC-ESI-QFT; MS2; CE: 42%; R=70000; [M-H]-
MSBNK-HBM4EU-HB002939
Cypermethrin-diOH (TENTATIVE)
1 spectrum
C13H10O4
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
230.05791
LC-ESI-QFT; MS2; CE: 42%; R=70000; [M-H]-
MSBNK-HBM4EU-HB002938
Cyproconazole (CP)
1 spectrum
C15H18ClN3O
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
291.11380
LC-ESI-QFT; MS2; CE: 40; R=70000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET210001
Cyprodinil
6 spectra
C14H15N3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
225.12660
LC-ESI-QFT; MS2; CE: 15; R=17500; [M+H]+
MSBNK-LCSB-LU081001
LC-ESI-QFT; MS2; CE: 30; R=17500; [M+H]+
MSBNK-LCSB-LU081002
LC-ESI-QFT; MS2; CE: 45; R=17500; [M+H]+
MSBNK-LCSB-LU081003
LC-ESI-QFT; MS2; CE: 60; R=17500; [M+H]+
MSBNK-LCSB-LU081004
LC-ESI-QFT; MS2; CE: 75; R=17500; [M+H]+
MSBNK-LCSB-LU081005
LC-ESI-QFT; MS2; CE: 90; R=17500; [M+H]+
MSBNK-LCSB-LU081006
Cyprodinil-TP CGA 249287
9 spectra
C8H11N3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
149.09531
LC-ESI-QFT; MS2; CE: 120%; R=17500; [M+H]+
MSBNK-Eawag-EQ417307
LC-ESI-QFT; MS2; CE: 15%; R=17500; [M+H]+
MSBNK-Eawag-EQ417301
LC-ESI-QFT; MS2; CE: 150%; R=17500; [M+H]+
MSBNK-Eawag-EQ417308
LC-ESI-QFT; MS2; CE: 180%; R=17500; [M+H]+
MSBNK-Eawag-EQ417309
LC-ESI-QFT; MS2; CE: 30%; R=17500; [M+H]+
MSBNK-Eawag-EQ417302
LC-ESI-QFT; MS2; CE: 45%; R=17500; [M+H]+
MSBNK-Eawag-EQ417303
LC-ESI-QFT; MS2; CE: 60%; R=17500; [M+H]+
MSBNK-Eawag-EQ417304
LC-ESI-QFT; MS2; CE: 75%; R=17500; [M+H]+
MSBNK-Eawag-EQ417305
LC-ESI-QFT; MS2; CE: 90%; R=17500; [M+H]+
MSBNK-Eawag-EQ417306
Cyproterone
1 spectrum
C22H27ClO3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
374.16486
LC-ESI-QFT; MS2; CE: 35 NCE; R=35000; [M+H]+
MSBNK-CASMI_2016-SM874501
Cyproterone acetate
6 spectra
C24H29ClO4
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
416.17542
LC-ESI-QFT; MS2; CE: 15; R=17500; [M+H]+
MSBNK-LCSB-LU031801
LC-ESI-QFT; MS2; CE: 30; R=17500; [M+H]+
MSBNK-LCSB-LU031802
LC-ESI-QFT; MS2; CE: 45; R=17500; [M+H]+
MSBNK-LCSB-LU031803
LC-ESI-QFT; MS2; CE: 60; R=17500; [M+H]+
MSBNK-LCSB-LU031804
LC-ESI-QFT; MS2; CE: 75; R=17500; [M+H]+
MSBNK-LCSB-LU031805
LC-ESI-QFT; MS2; CE: 90; R=17500; [M+H]+
MSBNK-LCSB-LU031806
Cyromazine
1 spectrum
C6H10N6
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
166.09669
LC-ESI-QFT; MS2; CE: 35 NCE; R=35000; [M+H]+
MSBNK-CASMI_2016-SM845603
Daidzein
4 spectra
C15H10O4
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
254.05791
LC-ESI-QFT; MS2; CE: 35 NCE; R=35000; [M+H]+
MSBNK-CASMI_2016-SM882802
LC-ESI-QFT; MS2; CE: 35 NCE; R=35000; [M-H]-
MSBNK-CASMI_2016-SM882851
LC-ESI-QFT; MS2; CE: Ramp 20%-70% (nominal); R=30000; [M+H]+
MSBNK-ACES_SU-AS000171
LC-ESI-QFT; MS2; CE: Ramp 20%-70% (nominal); R=30000; [M-H]-
MSBNK-ACES_SU-AS000239
Danazol
6 spectra
C22H27NO2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
337.20419
LC-ESI-QFT; MS2; CE: 15; R=17500; [M+H]+
MSBNK-LCSB-LU025301
LC-ESI-QFT; MS2; CE: 30; R=17500; [M+H]+
MSBNK-LCSB-LU025302
LC-ESI-QFT; MS2; CE: 45; R=17500; [M+H]+
MSBNK-LCSB-LU025303
LC-ESI-QFT; MS2; CE: 60; R=17500; [M+H]+
MSBNK-LCSB-LU025304
LC-ESI-QFT; MS2; CE: 75; R=17500; [M+H]+
MSBNK-LCSB-LU025305
LC-ESI-QFT; MS2; CE: 90; R=17500; [M+H]+
MSBNK-LCSB-LU025306
Danofloxacin
9 spectra
C19H20FN3O3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
357.14886
LC-ESI-QFT; MS2; CE: 120; R=35000; [M+H]+
MSBNK-Eawag-EQ366407
LC-ESI-QFT; MS2; CE: 150; R=35000; [M+H]+
MSBNK-Eawag-EQ366408
LC-ESI-QFT; MS2; CE: 15; R=35000; [M+H]+
MSBNK-Eawag-EQ366401
LC-ESI-QFT; MS2; CE: 180; R=35000; [M+H]+
MSBNK-Eawag-EQ366409
LC-ESI-QFT; MS2; CE: 30; R=35000; [M+H]+
MSBNK-Eawag-EQ366402
LC-ESI-QFT; MS2; CE: 45; R=35000; [M+H]+
MSBNK-Eawag-EQ366403
LC-ESI-QFT; MS2; CE: 60; R=35000; [M+H]+
MSBNK-Eawag-EQ366404
LC-ESI-QFT; MS2; CE: 75; R=35000; [M+H]+
MSBNK-Eawag-EQ366405
LC-ESI-QFT; MS2; CE: 90; R=35000; [M+H]+
MSBNK-Eawag-EQ366406
Dantrolene
6 spectra
C14H10N4O5
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
314.06509
LC-ESI-QFT; MS2; CE: 15; R=17500; [M-H]-
MSBNK-LCSB-LU099251
LC-ESI-QFT; MS2; CE: 30; R=17500; [M-H]-
MSBNK-LCSB-LU099252
LC-ESI-QFT; MS2; CE: 45; R=17500; [M-H]-
MSBNK-LCSB-LU099253
LC-ESI-QFT; MS2; CE: 60; R=17500; [M-H]-
MSBNK-LCSB-LU099254
LC-ESI-QFT; MS2; CE: 75; R=17500; [M-H]-
MSBNK-LCSB-LU099255
LC-ESI-QFT; MS2; CE: 90; R=17500; [M-H]-
MSBNK-LCSB-LU099256
Dapsone
15 spectra
C12H12N2O2S
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
248.06195
LC-ESI-QFT; MS2; CE: 120; R=35000; [M+H]+
MSBNK-Eawag-EQ364407
LC-ESI-QFT; MS2; CE: 150; R=35000; [M+H]+
MSBNK-Eawag-EQ364408
LC-ESI-QFT; MS2; CE: 15; R=17500; [M+H]+
MSBNK-LCSB-LU085701
LC-ESI-QFT; MS2; CE: 15; R=35000; [M+H]+
MSBNK-Eawag-EQ364401
LC-ESI-QFT; MS2; CE: 180; R=35000; [M+H]+
MSBNK-Eawag-EQ364409
LC-ESI-QFT; MS2; CE: 30; R=17500; [M+H]+
MSBNK-LCSB-LU085702
LC-ESI-QFT; MS2; CE: 30; R=35000; [M+H]+
MSBNK-Eawag-EQ364402
LC-ESI-QFT; MS2; CE: 45; R=17500; [M+H]+
MSBNK-LCSB-LU085703
LC-ESI-QFT; MS2; CE: 45; R=35000; [M+H]+
MSBNK-Eawag-EQ364403
LC-ESI-QFT; MS2; CE: 60; R=17500; [M+H]+
MSBNK-LCSB-LU085704
LC-ESI-QFT; MS2; CE: 60; R=35000; [M+H]+
MSBNK-Eawag-EQ364404
LC-ESI-QFT; MS2; CE: 75; R=17500; [M+H]+
MSBNK-LCSB-LU085705
LC-ESI-QFT; MS2; CE: 75; R=35000; [M+H]+
MSBNK-Eawag-EQ364405
LC-ESI-QFT; MS2; CE: 90; R=17500; [M+H]+
MSBNK-LCSB-LU085706
LC-ESI-QFT; MS2; CE: 90; R=35000; [M+H]+
MSBNK-Eawag-EQ364406
First
Prev
27
28
29
30
31
32
33
34
35
36
Next
Last
( Total
88
Page )
▲
Results Top
Imprint
Data Privacy
Feedback
system version 2.2.5
Copyright © 2006 MassBank Project; 2011
NORMAN Association
; 2021
MassBank Consortium
Search
Contents
Download
Documentation
About MassBank
News Archive
